Michael Earl Kahn

US Patent:

20020040282, Apr 4, 2002

Filed:

Mar 22, 2001

Appl. No.:

09/816649

Inventors:

Thomas Bailey - Kirkwood MO, US
Laura Noirot - St. Louis MO, US
Michael Kahn - Boulder CO, US
Sherry Steib - St. Louis MO, US

International Classification:

G06F015/00

US Classification:

702/188000

Abstract:

A clinical decision support application screens drug orders for drug dosing errors based on patient-specific information. The support application verifies that medication dosages are appropriately adjusted for renal function based upon calculated creatinine clearance (CrCI). In addition to looking for overdosing errors, other important features are its ability to detect under-dosing, and dosages and intervals that are not consistent with institution policy. The clinical decision support application also detects potentially dangerous drug combinations and serves as a safety net by providing a drug-drug interaction alert to a healthcare professional as well as reminders and escalations. Alert reports contain patient demographic data, the dose and start date of the interacting medications, pertinent laboratory or drug data, an educational comment with a recommendation for alternative therapy, and a customized outcome section that includes expected adverse events and treatment options for the detected interaction.